EventoWeb
Zürcher Hochschule für Angewandte Wissenschaften
[
German (Switzerland)
German (Switzerland)
] [
English
English
]
Not registered
[home]
[Login]
[Print]
Navigation
Kontakt zu Service Desk
Online-Dokumentation
Allgemeiner Zugriff
Module suchen
n.BA.XX.MZGÖEZ.23HS (Economic, Ethical and Regulatory Aspects of Cell and Tissue Therapies)
Module: Economic, Ethical and Regulatory Aspects of Cell and Tissue Therapies
This information was generated on: 15 May 2024
No.
n.BA.XX.MZGÖEZ.23HS
Title
Economic, Ethical and Regulatory Aspects of Cell and Tissue Therapies
Credits
2
Description
Version: 2.0 start 01 August 2023
Study Programme
Biotechnology / Chemistry
Regulations Applicable
RPO, 29 January 2008, School of Life Sciences and Facility Management Academic Regulations, 15 Dec. 2009, Annex for the Bachelor of Biotechnology degree programme
RPO, 29 January 2008, School of Life Sciences and Facility Management Academic Regulations, 15 Dec. 2009, Annex for the Bachelor of Chemistry degree programme
Module Type
X
Compulsory Module
Elective Module
Optional Module
Planned Semester
5th Semester
Module Coordinator
Prof. Dr. Jack Rohrer
Telephone / E-Mail
+41 (0)58 934 57 13 /
jack.rohrer@zhaw.ch
Lecturer(s),
Speaker(s),
Associate(s)
Jack Rohrer, Steffi Lehmann and guest lecturers
Entrance Requirements
Cell Biology 1, Cell Culture Techniques 1, Module Development and Production of Cell Therapeutics, Module Economic, Ethical and Regulatory Aspects of Cell and Tissue Therapies
Learning Outcomes and Competencies
The lecture series aims at enabling participants to understand the most important economic, ethical, and regulatory aspects of cell and tissue therapies. For this purpose, experienced experts from the industry will be consulted for selected topics.
Module Content
Technologies in regenerative therapy and quality control aspects (excursion to Wyss Center)
Methods for demonstrating therapeutic efficacy
Approval of cell and tissue therapeutics (practical experience report)
Application of CAR-T technology in patients: from development to approval (excursion to Novartis Stein)
The potential of organ-on-a-chip technology
Ethical aspects of cell and tissue therapy
Follow-up Modules
None
Methods of Instruction
Lecture, practice exercises, excursions
Digital Resources
Videos
Lesson Structure / Workload
Contact Hours
30
Guided Self-Study
10
Independent Self-Study
20
Total Workload
60
Classroom Attendance
None
Assessment
Coursework 100%: Graded report on excursion (4 students per group)
Language of Instruction
German
Comments
The module Economic, Ethical, and Regulatory Aspects of Cell and Tissue Therapies is part of the Minor Cell and Tissue Therapy module group.
Bibliography
Lecture slides
M. R. Topcul, I. Cetin (2018) Stem cells in cell therapy and regenerative medicine. OMICS International. ISBN 978-1-63278-021-8-22
S. Gerke, J. Taupitz, C. Wiesemann, C. Kopetzki, H. Zimmermann (2020) Die klinische Anwendung von humanen induzierten pluripotenten Stammzellen. Springer.
ISSN 1617-1497
N. Kröger, J. Gribben, C. Chabannon, I. Yakoub-Agha, H. Einsele (2022) The EBMT/EHA CAR-T Cell Handbook.
Springer. ISBN 978-3-030-94352-3
D. Singh, A. Mathur, S. Arora, S. Roy, N. Mahindroo (2022) Journey of organ on a chip technology and its role in future healthcare scenario.
doi:
10.1016/j.apsadv.2022.100246
Course: Economic, Ethical and Regulatory Aspects of Cell and Tissue Therapies
No.
n.BA.XX.MZGÖEZ.23HS.V
Title
Economic, Ethical and Regulatory Aspects of Cell and Tissue Therapies
Note
No module description is available in the system for the cut-off date of 15 May 2024.